Pasar al contenido principal

BIOSENSORES ELECTROQUIMICOS EMPODERADOS PARA TRAZAR NUEVAS HOJAS DE RUTA HACIA LA MEDICINA PERSONALIZADA DEL CANCER, EL ALZHEIMER Y LAS ENFERMEDADES INFECCIOSAS VIRALES

PID2022-136351OB-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal para Impulsar la Investigación Científico-Técnica y su Transferencia
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2022
Plan Estatal 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario UNIVERSIDAD COMPLUTENSE DE MADRID

Resultados relacionados

Resultados totales (Incluyendo duplicados): 10
Encontrada(s) 1 página(s)

Docta Complutense
Publicación Artículo científico (JournalArticle)

Contributing to the management of viral infections through simple immunosensing of the arachidonic acid serum level

  • Torrente Rodríguez, Rebeca Magnolia
  • Ruiz Valdepeñas Montiel, Víctor
  • Iftimie, Simona
  • Montero Calle, Ana
  • Pingarrón Carrazón, José Manuel
  • Castro, Antoni
  • Camps, Jordi
  • Barderas Manchado, Rodrigo
  • Campuzano Ruiz, Susana
  • Joven, Jorge
A trendsetting direct competitive-based biosensing tool has been developed and implemented for the determination of the polyunsaturated fatty acid arachidonic acid (ARA), a highly significant biological regulator with decisive roles in viral infections. The designed methodology involves a competitive reaction between the target endogenous ARA and a biotin-ARA competitor for the recognition sites of anti-ARA antibodies covalently attached to the surface of carboxylic acid-coated magnetic microbeads (HOOC-MμBs), followed by the enzymatic label of the biotin-ARA residues with streptavidin-horseradish peroxidase (Strep-HRP) conjugate. The resulting bioconjugates were magnetically trapped onto the sensing surface of disposable screen-printed carbon transducers (SPCEs) to monitor the extent of the biorecognition reaction through amperometry. The operational functioning of the exhaustively optimized and characterized immunosensing bioplatform was highly convenient for the quantitative determination of ARA in serum samples from severe acute respiratory syndrome coronavirus 2 (SARSCoV-2-) and respiratory syncytial virus (RSV)-infected individuals in a rapid, affordable, trustful, and sensitive manner.
Docta Complutense
Publicación Artículo científico (JournalArticle)

Hierarchical Au@Pt nanoparticle/amino benzoic acid polymer‑based hybrid material for labeled and label‑free detection of interleukin‑6: a comparative assessment

  • Soto, Dayana
  • Serafín González-Carrato, Verónica
  • Pedrero Muñoz, María
  • Pingarrón Carrazón, José Manuel
  • Campuzano Ruiz, Susana
  • Orozco, Jahir
Interleukin-6 (IL6) is a cytokine mainly involved in inflammatory processes associated with various diseases, from rheumatoid arthritis and pathogen-caused infections to cancer, where malignant cells exhibit high proliferation and overexpression of cytokines, including IL6. Furthermore, IL6 plays a fundamental role in detecting and differentiating tumor cells, including colorectal cancer (CRC) cells. Therefore, given its range of biological activities and pathological role, IL6 determination has been claimed for the diagnosis/prognosis of immune-mediated diseases. Herein, a comparative study is presented of labeled and label-free electrochemical immunosensors involving a hierarchical Au@Pt nanoparticle/polymer hybrid material for detecting IL6. The electrochemical immunosensors were independently coupled to the surface of screen-printed carbon electrodes (SPCEs) previously modified with polymeric layers. While in the label-free immunosensor, an anti-IL6 antibody (IL6-Ab) was covalently bound to the modified SPCE surface, in the sandwich-like amperometric immunosensor, an anti-biotinylated-IL6 antibody (B-IL6-Ab) was attached to the electrode through biotin-avidin affinity interactions. The label-free format employed a straightforward detection of IL6 by differential pulse voltammetry (DPV). The resulting electrochemical immunosensors exhibited a linear dynamic range from 50 to 750 pg/mL IL6, with detection limits (LOD) of 14.4 and 6.0 pg/mL for label-free and sandwich-like immunosensors, respectively. This outstanding performance makes them versatile platforms for clinical analysis of a panel of biomarkers for early diagnosis/prognosis of inflammatory processes associated with oncological diseases, among other pathologies.
Docta Complutense
Publicación Artículo científico (JournalArticle)

Gold-silica hybrid nanolabels decorated with recognition and signaling bioreagents for enhanced electrochemical immunodetection of chemokine ligand-12 in colorectal cancer early diagnosis and monitoring

  • Cabrero Martín, Andrea
  • Santiago, Sara
  • Serafín González-Carrato, Verónica
  • Montero Calle, Ana
  • Pingarrón Carrazón, José Manuel
  • Barderas Manchado, Rodrigo
  • Campuzano Ruiz, Susana
The use of gold–silica nanoconjugates (Au@SiO₂NCs) decorated with biotinylated detection antibodies (b-dAb) and horseradish peroxidase (HRP) is reported for the improved electrochemical immunosensing of chemokine ligand-12 (CXCL12), a relevant chemokine implicated in colorectal cancer (CRC) progression. Implemented on an amperometric sandwich immunoplatform the resulting nanobioconjugates provided significant signal amplification which is attributed to the high enzyme loading capacity and improved antibody orientation. The role played by each of the nanomaterials forming the nanohybrid was evaluated. Under optimized conditions, the developed immunoplatform exhibited a linear response ranging from 72 to 1000 pg mL−1, a 4 times higher sensitivity than the conventional labeling-based immunoplatform, a LOD of 22 pg mL−1, and a storage stability of 1 month. The immunoplatform was applied to the determination of CXCL12 in plasma from healthy individuals and CRC patients. The clinically relevant results obtained demonstrate the potential of plasma CXCL12 levels as a biomarker for both the early diagnosis of CRC and the monitoring of its progression.
Repisalud
Publicación Artículo científico (JournalArticle)

Determining and characterizing circulating nucleosomes in advanced cancer with electrochemical biosensors assisted by magnetic supports and proteomic technologies.

  • Tejerina-Miranda, Sandra
  • Carral-Ibarra, Elisa
  • Gamella, Maria
  • Montero-Calle, Ana Maria
  • Pedrero, María
  • Pingarrón, José M
  • Barderas Manchado, Rodrigo
  • Campuzano, Susana
Measuring and monitoring plasma nucleosomes (small fragments of chromosomes released into the blood during cell death), and their proteomic profiles is a promising approach for improved early detection, diagnosis, and prognosis of cancer diseases as well as for disease and therapy follow-up, contributing to more personalized and effective cancer care. Early detection is imperative in colorectal cancer (CRC), as it has been proven to significantly improve patient outcomes. Indeed, in CRC, blood circulating nucleosome levels and their histone alterations have been correlated with tumor stage and the presence of metastasis. Moreover, they constitute promising markers for CRC monitoring and prognosis in a minimally invasive way. The current technologies used for their detection suffer from notable drawbacks such as non-selective identification and quantification of unknown cancer-relevant proteomic trademarks, expensive procedures, and variable results related to staff experience. Taking advantage of the sensitive, fast, cost-effective, and reliable methodologies that electroanalytical technologies offer for the determination of multilevel biomarkers in liquid biopsies, we report in this paper the first electrochemical immunoplatform for the isolation and determination of circulating nucleosomes in plasma using an anti-H3.1 histone variant, integrated with proteomics insights to confirm nucleosomes isolation and identify associated proteins with potential as CRC biomarkers. The developed bioplatform was used to analyze 0.5 μg of nuclear extracts from CRC cells with different metastatic potential as well as 1/5 diluted plasma samples, demonstrating the suitability to effectively discriminate CRC patients in advanced stages from healthy individuals through liquid biopsy.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Disposable amperometric biotool for peanut detection in processed foods by targeting a chloroplast DNA marker

  • Gamella, María
  • Ballesteros, Isabel
  • Ruiz-Valdepeñas Montiel, Víctor
  • Sanchiz, Africa
  • Cuadrado Hoyos, María Carmen
  • Pingarrón, José Manuel
  • Linacero, Rosario
  • Campuzano, Susana
10 Pág., This work reports the development and application of a disposable amperometric sensor built on magnetic microcarriers coupled to an Express PCR strategy to amplify a specific DNA fragment of the chloroplast trnH-psbA. The procedure involves the selective capture of a 68-mer synthetic target DNA (or unmodified PCR products) through sandwich hybridization with RNA capture probe-modified streptavidin MBs and RNA signaling probes, labeled using antibodies specific to the heteroduplexes and secondary antibodies tagged with horseradish peroxidase. Amperometric measurements were performed on screen-printed electrodes using the H2O2/hydroquinone system. Achieving a LOD of 3 pM for the synthetic target, it was possible to detect 2.5 pg of peanut DNA and around 10 mg kg-1 of peanut in binary mixtures (defatted peanut flours prepared in spelt wheat). However, the detectability decreased between 10 and 1000 times in processed samples depending on the treatment. The Express PCR-bioplatform was applied to the detection of peanut traces in foodstuff., The financial support of Grants AGL2017-83082-R, PID2021-122942OB-I00 and PID2022-136351OB-I00 funded by MCIN/AEI/10.13039/501100011033 and by “ERDF A way of making Europe” is gratefully acknowledged., Peer reviewed
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Electrochemical immunosensing of walnut and hazelnut allergenic proteins in processed foods

  • Tvorynska, Sofiia
  • Civera, Alba
  • Gamella, Maria
  • Torrente-Rodríguez, Rebeca M.
  • Pedrero, María
  • Galán-Malo, Patricia
  • Mata, Luis
  • Sánchez, Lourdes
  • Barek, Jirí
  • Pingarrón, José M.
  • Pérez, María D.
  • Campuzano, Susana
Nuts are a well-known cause of food allergy and, once this has been diagnosed, due to the likelihood of cross-sensitization to multiple tree nut allergens, their strict avoidance from the diet is advisable. In this context, we present electrochemical bioplatforms to detect traces of hazelnut and walnut in processed foods through the determination of their respective allergenic proteins Cor a 9 and Jug r 1 in a fast and sensitive assay. First, the evaluation of the single determination of both proteins was performed by building sandwich immunoconjugates on the surface of magnetic microbeads relying on specific antibodies unmodified or conjugated to horseradish peroxidase. Amperometric transduction was made upon trapping the magnetic bioconjugates on the surface of disposable carbon electrodes, using the hydroquinone/hydrogen peroxide system. The great analytical performance achieved with the individual platforms (detection limits of 0.12 and 0.56 ng mL−1 for Jug r 1 and Cor a 9, respectively), led us to the individual and dual quantification of both proteins in raw dough and baked cookies incurred with ground nuts. The developed method allowed detecting baked cookies incurred with 0.0025% ground walnut and 0.00002% ground hazelnut with results comparable to those provided by ELISA techniques. The feasibility of performing the dual determination of both allergens in a single run was demonstrated.
Docta Complutense
Publicación Artículo científico (JournalArticle)

Bringing to light the importance of the mirna methylome in colorectal cancer prognosis through electrochemical bioplatforms

  • Povedano Muñumel, Eloy
  • Ruiz Valdepeñas Montiel, Víctor
  • Sebuyoya, Ravery
  • Torrente Rodríguez, Rebeca Magnolia
  • Garranzo Asensio, María
  • Montero Calle, Ana
  • Pingarrón Carrazón, José Manuel
  • Barderas Manchado, Rodrigo
  • Bartosik, Martin
  • Campuzano Ruiz, Susana
This work reports the first electrochemical bioplatforms developed for the determination of the total contents of either target miRNA or methylated target miRNA. The bioplatforms are based on the hybridization of the target miRNA with a synthetic biotinylated DNA probe, the capture of the formed DNA/miRNA heterohybrids on the surface of magnetic microcarriers, and their recognition with an antibody selective to these heterohybrids or to the N6-methyladenosine (m6A) epimark. The determination of the total or methylated target miRNA was accomplished by labeling such secondary antibodies with the horseradish peroxidase (HRP) enzyme. In both cases, amperometric transduction was performed on the surface of disposable electrodes after capturing the resulting HRP-tagged magnetic bioconjugates. Because of their increasing relevance in colorectal cancer (CRC) diagnosis and prognosis, miRNA let-7a and m6A methylation were selected. The proposed electrochemical bioplatforms showed attractive analytical and operational characteristics for the determination of the total and m6A-methylated target miRNA in less than 75 min. These bioplatforms, innovative in design and application, were applied to the analysis of total RNA samples extracted from cultured cancer cells with different metastatic profiles and from paired healthy and tumor tissues of patients diagnosed with CRC at different stages. The obtained results demonstrated, for the first time using electrochemical platforms, the potential of interrogating the target miRNA methylation level to discriminate the metastatic capacities of cancer cells and to identify tumor tissues and, in a pioneering way, the potential of the m6A methylation in miRNA let-7a to serve as a prognostic biomarker for CRC.
Docta Complutense
Publicación Artículo científico (JournalArticle)

Estudiando la senescencia celular en cáncer colorrectal con inmunosensado electroquímico moderno

  • Pedrero Muñoz, María
  • Tejerina Miranda, Sandra
  • Gamella Carballo, María
  • Montero Calle, Ana
  • Pingarrón Carrazón, José Manuel
  • Barderas Manchado, Rodrigo
  • Campuzano Ruiz, Susana
Con la edad, en un número creciente de células del organismo se producen daños en el DNA que derivan en senescencia celular [1]. Las células senescentes se acumulan en los tejidos creando microambientes protumorales y aumentando la expresión de diversos biomarcadores, entre los que cabe destacar el factor de diferenciación de crecimiento 15 (GDF-15) y el inhibidor tisular de la metaloproteinasa 1 (TIMP-1), ambos implicados en procesos de senescencia celular y metástasis en cáncer colorrectal (CRC) [2-4]. Con el propósito de profundizar en el papel de dichos biomarcadores en estos procesos, recientemente se han desarrollado inmunoplataformas electroquímicas aplicadas con éxito al análisis de extractos y secretomas de células de CRC con diferente capacidad metastásica y de plasma y tejido de pacientes con CRC en distintos estadios. Los resultados obtenidos han puesto en valor el papel que juegan estos dos biomarcadores en el entendimiento y tratamiento de estos trastornos.
Docta Complutense
Publicación Artículo científico (JournalArticle)

Bioelectroanalytical Technologies for Advancing the Frontiers To Democratize Personalized Desired Health

  • Campuzano Ruiz, Susana
  • Ruiz Valdepeñas Montiel, Víctor
  • Torrente Rodríguez, Rebeca Magnolia
  • Pingarrón Carrazón, José Manuel
The breakthroughs experienced in the development of cutting-edge, reliable, and multipurpose (bio)electroanalytical technologies and their successful incursion into underexplored scenarios have demonstrated their unique potential to act as enablers of the ongoing transformation from reactive to predictive, preventive, personalized, and participatory healthcare, currently known as “P4” medicine. This transformation, more than a vision, is a necessity to achieve a new generation of more efficient, sustainable, and tailored to individual needs healthcare. This promising outlook is the focus of this Perspective, which in addition to highlighting some of the most shocking related research over the last 5 years, offers a prospective and insightful view of the opportunities and imminent advances that shape the future of these fascinating technologies.
Docta Complutense
Publicación Artículo científico (JournalArticle)

Disposable amperometric biotool for peanut detection in processed foods by targeting a chloroplast DNA marker

  • Gamella Carballo, María
  • Ballesteros Redondo, María Isabel
  • Ruiz Valdepeñas Montiel, Víctor
  • Sánchiz, Africa
  • Cuadrado, Carmen
  • Pingarrón Carrazón, José Manuel
  • Linacero De La Fuente, M. Rosario
  • Campuzano Ruiz, Susana
This work reports the development and application of a disposable amperometric sensor built on magnetic microcarriers coupled to an Express PCR strategy to amplify a specific DNA fragment of the chloroplast trnH-psbA. The procedure involves the selective capture of a 68-mer synthetic target DNA (or unmodified PCR products) through sandwich hybridization with RNA capture probe-modified streptavidin MBs and RNA signaling probes, labeled using antibodies specific to the heteroduplexes and secondary antibodies tagged with horseradish peroxidase. Amperometric measurements were performed on screen-printed electrodes using the H2O2/hydroquinone system. Achieving a LOD of 3 pM for the synthetic target, it was possible to detect 2.5 pg of peanut DNA and around 10 mg kg−1 of peanut in binary mixtures (defatted peanut flours prepared in spelt wheat). However, the detectability decreased between 10 and 1000 times in processed samples depending on the treatment. The Express PCR-bioplatform was applied to the detection of peanut traces in foodstuff.